Organ on a Chip Technology: Discussion with Yaakov Nahmias (INTERPHEX 2023)
Yaakov Nahmias, founder and chief scientific officer of Tissue Dynamics, discusses the barriers in implementing organ on a chip technology.
Yaakov Nahmias, founder and chief scientific officer of Tissue Dynamics, and one of the INTERPHEX Keynote speakers in the Organ on a Chip for Pharmaceutical Development session, discusses the barriers in implementing organ on a chip technology as well as the need for researchers and scientists to think critically about the data generated from this technology for pharmaceutical development.
For more INTERPHEX 2023 video content, check this page for updates.
How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)
November 29th 2022Allison Labriola, Senior Technical Sales Representative, at JRS Pharma is interviewed by the Editorial Director of Pharmaceutical Technology Chris Spivey about how the food industry is affecting the pharmaceutical industry.
AAPS PharmSci 360 2024: Predictive Models for Poorly Soluble Drugs
October 10th 2024Pharmaceutical Technology sat down with Niloufar Salehi, advisor at Eli Lilly & Company, to talk about the session she is moderating at AAPS PharmSci 360 2024, Symposium: An Accelerated Development of Poorly Soluble Drugs Using Predictive Tool.
